News
-
-
PRESS RELEASE
Jaguar Health Receives Fee Waivers from FDA
Napo Pharmaceuticals and Jaguar Health receive waivers from FDA for Mytesi and Canalevia fees for 2027. Jaguar develops GI drugs from plants; focus on rare disorders and mental health. For safety information, visit Mytesi.com and Canalevia.com -
-
-
-
PRESS RELEASE
Life Science Intelligence partners with Opus Origin to accelerate the expansion of its premium global platforms for medtech innovation and investment
Life Science Intelligence partners with Opus Origin to accelerate the expansion of its global platforms for medtech innovation and investment, enhancing capabilities in data, research, and AI while expanding events and media coverage -
-
-
-